To get result click hereSubscription Open: June 20, 2010Subscription Close: June 24, 2010For Non-Resident Bangladeshi: June 20, 2010 to July 03, 2010Reason for IPO To meet the working capital requirement.Offer Price Per Share Tk. 10.00Face Value Per Share Tk. 10.00Market Lot (Shares) 500Pre-IPO Paid-up Capital Tk. 1,900,000,000.00Public Offer (Shares) 30,000,000Total Issued Shares (after IPO) 220,000,000Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)NAV Per Share (after revaluation; as per Prospectus) Tk.16.05 (as on 30.06.2009)Website: www.beacon-pharma.comNature of Business:The Company is engaged in manufacturing andmarketing of pharmaceuticals finished FormulationProducts and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, ActivePharmaceuticals Ingredients (APIs), Bio-tech products& Genetic Engineering products which it sells in thelocal markets. The Company also provides contractmanufacturing and tool manufacturing services.Beacon Pharmaceuticals Ltd.At a glanceBeacon Pharmaceuticals Limited (BPL) is a public limited comp fiat currency any, which wasincorporated in Bangladesh on 12 September 2001 as private limited companywith the Registrar of Joint Stock Companies and Firms, Dhaka, Bangladeshunder the Companies Act 1994 with a mission to improve the quality of humanlife by providing innovating pharmaceutical products through continuousresearch and development and by ensuring stakeholders satisfaction.The company went into commercial operation on 01 September 2006 by usingits two or three product lines. The status of the company was covered fromPrivate Limited to Public Limited Company on 25th February 2008. TheAuthorized Capital of the Company as of 30 April 2009 is Tk.250, 00,00,000divided into 25,00,00,000 ordinary shares of Tk. 10.00 each. The paid-up sharecapital as of the same date was Tk 600,000,000 divided into 60,000,000ordinary shares of Tk.10.00 each. Subsequently the Company issued100,000,000 ordinary shares of Tk. 10.00 each amounting to Tk.1,000,000,000.00 on 27.09.2009 which consent has been accorded by theSecurities and Exchange Commission on 04.08.2009; and the Company isgoing to subscribe 30,000,000 ordinary shares of Tk. 10.